Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Assistant Secretary Noyes Travel to Colombia and Florida
    Assistant Secretary Noyes Travel to Colombia and Florida World News
  • Black Briar Advisors Named “Best Companies to Watch in 2023” by The CIO Bulletin
    Black Briar Advisors Named “Best Companies to Watch in 2023” by The CIO Bulletin World News
  • Cranes Market Size, Share And Growth Analysis For 2024-2033
    Cranes Market Size, Share And Growth Analysis For 2024-2033 World News
  • Ledes Schedule 40 & 80 Rigid PVC Conduit
    Ledes Schedule 40 & 80 Rigid PVC Conduit Aviation
  • Savvy Cleaner Strikes Gold on Live Shopping Show With New Assistant Producer Jenifer Holland
    Savvy Cleaner Strikes Gold on Live Shopping Show With New Assistant Producer Jenifer Holland Business
  • Austin Airport is First in Nation to Get Advanced Tower Simulator, Boosting Controller Training and Safety
    Austin Airport is First in Nation to Get Advanced Tower Simulator, Boosting Controller Training and Safety Aviation
  • FAA Gives Kids Opportunity to Design Airports
    FAA Gives Kids Opportunity to Design Airports Aviation
  • Hari Krishna Exports’ Second Generation Leader Named 40 Under 40 Awardee at IIJS Premier 2024
    Hari Krishna Exports’ Second Generation Leader Named 40 Under 40 Awardee at IIJS Premier 2024 World News
Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Posted on November 15, 2024 By NewsEditor

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular Inc

Solaris SX is very flexible

Solaris SX Flexibility

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /EINPresswire.com/ — Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery Disease (PAD). Solaris Endovascular develops evidence-based technologies, intended to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries to allow patients to lead healthier lives with fewer interventions.

End-Stage Kidney Disease (ESKD) is a major health concern affecting approximately 10 million people worldwide with approximately 3 million people receiving kidney replacement therapy and relying on hemodialysis to survive. Over 50% of these patients experience vascular access failures within the first year and are subjected to hospital admissions and repeated costly endovascular or surgical interventions to restore their lifeline to dialysis—this drastically impacts quality of life, treatment effectiveness and survival.

In April 2024, the American Heart Association reported that the global prevalence of peripheral artery disease (PAD) may be as high as 230 million people. PAD can progress from painful walking to critical limb ischemia, and many patients require revascularization procedures to restore blood flow, improve symptoms, or prevent amputations.

Stent-grafts are emerging as the preferred minimally invasive treatment for these conditions and Solaris Endovascular is currently selling the latest generation of stent-grafts. The flagship Solaris(TM) SX Vascular Stent Graft employs the most advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. This thin, multi-directional PTFE membrane encapsulates a nitinol stent that provides flexibility, high radial strength, and crush resistance for optimal blood flow. These features are already proven in global markets with more than 13,000 units sold to date. Interventional and endovascular physicians worldwide have chosen Solaris SX for its trackability and precise pinpoint deployment, ensuring accurate placement.

“Bringing this innovative technology to the United States is a major step forward in improving the lives of patients,” said Dr. Marco Costa, Chairman and Chief Medical & Scientific Officer at Solaris Endovascular Inc. “Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet need in covered stents: edge stenosis. Solaris DE incorporates Sirolimus, a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination of restenosis, from 30% to 3%.

“We expect Solaris DE to deliver similar transformative results to patients with ESKD and PAD,” said Dr. Costa.

CEO Randy Hubbell emphasized the company’s unique position in the market: “Solaris Endovascular represents a rare opportunity to start a new company that is revenue producing from the beginning, has a decade-plus manufacturing expertise in stents, stent grafts and endovascular drug delivery, and a proven product supported by clinical studies in multiple markets before entering the U.S. Our platform addresses a significant unmet need in both dialysis access and PAD, offering life-changing solutions for patients while setting a new standard in endovascular care.”

As Solaris Endovascular prepares for the U.S. registration process, it is committed to driving meaningful improvements in patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs.

About Solaris Endovascular, Inc.

Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.

For more information, please visit: [www.solarisendovascular.com]

Randy Hubbell
Solaris Endovascular, Inc.
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 13, 2024, 13:30 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Beauty & Hair Care, Business & Economy, Chemical Industry, Companies, Conferences & Trade Fairs, Culture, Society & Lifestyle, Education, Emergency Services …


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Business

Post navigation

Previous Post: Maria Cecilia Conder selected as Top Board Member of the Year in Fine Arts by IAOTP
Next Post: Tech and Social Impact Leaders Converge at Goodera’s AI for Impact Summit

Related Posts

  • PPC Flexible Packaging, LLC Announces Acquisition of Plastic Packaging Technologies, LLC
    PPC Flexible Packaging, LLC Announces Acquisition of Plastic Packaging Technologies, LLC Business
  • Global Castor Oil And Derivatives Market Is Projected To Grow At A 5.86 % Rate Through The Forecast Period
    Global Castor Oil And Derivatives Market Is Projected To Grow At A 5.86 % Rate Through The Forecast Period Business
  • NoOnes Announces Zero Fees on USDT Trades in Argentina
    NoOnes Announces Zero Fees on USDT Trades in Argentina Business
  • Anti-Counterfeit Packaging Market Is Booming Worldwide
    Anti-Counterfeit Packaging Market Is Booming Worldwide Business
  • Loader Global Market 2024 To Reach .3 Billion By 2028 At Rate Of 4.6%
    Loader Global Market 2024 To Reach $29.3 Billion By 2028 At Rate Of 4.6% Business
  • Successful 2022 Milestones Support Value of Gb Sciences’ AI-Enabled Drug Discovery Platform
    Successful 2022 Milestones Support Value of Gb Sciences’ AI-Enabled Drug Discovery Platform Business
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • BusinessCardDesigners.com Launches Custom Business Card StudioSeptember 21, 2025
  • BioVeritas to Speak at Argus North American Biofuels, LCFS & Carbon Markets SummitSeptember 21, 2025
  • Fibank is the Best Bank for Customer Experience in Bulgaria according to EuromoneySeptember 20, 2025
  • Most American Voters Would Accept U.S.-Backed Israeli-Palestinian PeaceSeptember 20, 2025
  • Libertine forms joint ventures in Saudi Arabia and Hong Kong to commercialise intelliGEN linear generatorsSeptember 19, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • More Electric Aircraft Market Size Expected to Reach .2 Billion by 2033
    More Electric Aircraft Market Size Expected to Reach $11.2 Billion by 2033 Aviation
  • From poverty to politics: Meet ‘Brazil’s AOC’ – BBC News
    From poverty to politics: Meet ‘Brazil’s AOC’ – BBC News World News
  • Assistant Secretary Noyes Travel to Colombia and Florida
    Secretary Blinken’s Call with Palestinian President Abbas World News
  • Exec Capital launches International Team
    Exec Capital launches International Team Business
  • War Day 159: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 159: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Christopher Bennett to Lead C4 Consulting’s (Behavioral Health Consulting) National Business Development
    Christopher Bennett to Lead C4 Consulting’s (Behavioral Health Consulting) National Business Development Business
  • Erica Whitfield’s Campaign Gains Momentum with Broad Coalition and Top-Tier Team
    Erica Whitfield’s Campaign Gains Momentum with Broad Coalition and Top-Tier Team Business
  • Delran, NJ Deployed Non UCC Permit Module With GovPilot
    Delran, NJ Deployed Non UCC Permit Module With GovPilot World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .